ESC Congress 2017

26 - 30 August 2017, Barcelona - Spain

Session Details

Poster session 5 : Trans-catheter valve interventions and their complications
Mon 28 Aug 14:00 - 18:00 Miscellaneous Poster Session Posters - Poster Area
Learning Objectives: Posters are on display from 14:00 – 18:00. Presenters will be by their poster during the coffee break from 15:30 and 16:30 for posters viewing time

Abstract Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Related documents
14:00P4263Outcomes in a resource-constrained economy: results from the multi-centre South African SHARE-TAVI registryHellmuth WEICH (Tygerberg, South Africa)
14:00P4264Risk factors and outcome of postoperative delirium after transcatheter aortic valve replacementPeter STACHON (Freiburg, Germany)
14:00P4265Impact of reduced left ventricular ejection fraction on outcomes after transcatheter aortic valve implantationAntonio Jesus MUNOZ GARCIA (Malaga, Spain)
14:00P4266Prognostic value of heart failure before and during the first year after TAVI. Factors determining heart failure after TAVI.Rocio GONZALEZ FERREIRO (Santiago De Compostela, Spain)
14:00P4267Incidence, predictive and prognostic factors of hospitalization for cardiac heart failure in patients implanted with TAVREric DURAND (Rouen, France)
14:00P4268Early and mid-term improvement in left ventricle mechanics after transcatheter aortic valve replacementVanesa Cristina LOZANO-GRANERO (Madrid, Spain)
14:00P4269Prognostic impact of obesity after transcatheter aortic valve implantation in patients with severe aortic valve stenosisFlorian DEUSCHL (Hamburg, Germany)
14:00P4270Short- and long-term clinical outcomes in nonagenarian patients undergoing transcatheter aortic valve implantation Adriano CAIXETA (Sao Paulo, Brazil)
14:00P4271Should we give anticoagulants to all patients implanted with transcatheter heart valves ?Francois HUCHET (Carquefou, France)
14:00P4272Aortic valve hemodynamic deterioration after transcatheter aortic valve implantation (TAVI) and its association with anti-thrombotic therapy.Claudio Manuel ESPADA GUERREIRO (Lisboa, Portugal)
14:00P4273Patterns of an early platelet response after TAVI are equal for various types and sizes of implanted valves, but its magnitude differs across valve diameters.Lukasz KALINCZUK (Warsaw-Anin, Poland)